What's new

Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation: 14/01/2015, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation: 14/01/2015, Revision: 27, Status: Authorised

Mar 10, 2025 - 15:03
 0
Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation: 14/01/2015, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation: 14/01/2015, Revision: 27, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Mineralys Therapeutics stock soars on blood pressure drug data

Next Article

Watches of Switzerland launches share buyback programme

Related Posts

Human medicines European public assessment report (EPAR): Dafiro HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Human variation electronic application form (eAF) training session and Q&A clinic, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 November 2024, 10:00 (CET) to 8 November 2024, 11:00 (CET)

Human variation electronic application form (eAF) train...

Mar 7, 2025  0

EMEA-002798-PIP04-23

EMEA-002798-PIP04-23

Feb 13, 2025  0